Stroke is the second-most common cause of death worldwide. The pathophysiology of
ischemic stroke (IS) is related to inflammation, atherosclerosis, blood coagulation, and …

MicroRNAs (miRNAs) are present in serum and have the potential to serve as disease
biomarkers. As such, it is important to explore the clinical value of miRNAs in serum as …

Stroke is one of the leading causes of death and physical disability worldwide. The
consequences of stroke injuries are profound and persistent, causing in considerable …

Stroke continues to be the third-leading cause of death and disability worldwide. The limited
availability of diagnostic tools approved therapeutics and biomarkers that help monitor …

Background Many diseases include microRNAs (miRNAs) as reported biomarkers. The
significance of circulating miRNAs for early diagnosis of acute stroke in humans is unknown …

Background Acute ischemic stroke is a leading cause of death and disability worldwide.
Unlike myocardial infarction, there is no current blood test to diagnose acute ischemic …

Ischemic stroke is one of the leading causes of death worldwide. Clinical manifestations of
stroke are long-lasting and causing economic burden on the patients and society. Current …

Stroke is one of the most devastating diseases worldwide. In recent years, a great number of
studies have focused on the effects of microRNAs (miRNAs) on stroke and the results …

Stroke is one of the leading causes of death and disability in both developing and
developed countries. Biomarkers for stroke and its outcome can greatly facilitate early …

Stroke is a life‐threatening disease that accounts for a considerable burden of mortality in
both developing and developed world. Identification of specific biomarkers for stroke and its …